-
The metabolic syndrome affects more than 1 in 5 Americans and is increased substantially in Mexican Americans and by several modifiable lifestyle factors.
-
The findings of this study, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.
-
A randomized, diet-controlled interventional study demonstrates that moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels.
-
Low intensity warfarin therapy effectively prevents recurrent venous thromboembolism, according to a recent study in the New England Journal of Medicine.
-
On February 26th, the FDA approved a transdermal formulation of oxybutynin for the treatment of overactive bladder and urinary incontinence. Oxytrol Patch (Watson Pharmaceuticals) provides 3.9 mg/d and can be administered twice per week.
-
This population report investigated the prevalence of gluten sensitivity amongst a large cohort of patients with both sporadic and familial ataxia.
-
Almost all patients with diabetes eventually develop neuropathy. New therapeutic options for the control of painful diabetic neuropathy are constantly being investigated.
-
-
Mutations in a-synuclein and parkin have been described in families with Parkinsons disease, and both gene products are involved in the function of the proteosome, a major pathway for degradation of proteins within the cell.
-
HMG-CoA reductase inhibitors (statins) are known to reduce the risk of myocardial infarction and stroke. Statins are effective not only as cholesterol lowering agents but also have beneficial effects on endothelial cell function, as well as antithrombotic and anti-inflammatory effects.